Iran J Vet Surg, Print ISSN: 2008-3033, Online ISSN: 2676-6299

Document Type : Original Article


Department of Clinical Sciences, Faculty of Veterinary Medicine, Urmia Branch, Islamic Azad University, Urmia, Iran.


Objective- To studylocal effect of prostaglandin E1on sciatic nerve regeneration
Design- Experimental study
Animals- Sixty male healthy white Wistar rats
Procedures- Sixty animals were divided into four experimental groups (n = 15), randomly: Trasnsected (TC), Sham-operation (SHAM), control (CHIT) and prostaglandin E1treated (CHIT/PGE) groups. In SHAM group after anesthesia left sciatic nerve was exposed through a gluteal muscle incision and after homeostasis muscle was sutured. In CHIT group the left sciatic nerve was exposed the same way and transected proximal to tibio-peroneal bifurcation leaving a 10-mm gap. Proximal and distal stumps were each inserted into a chitosan conduit and filled with 10 µL phosphate buffered solution. In CHIT/PGE group defect was bridged using a chitosan conduit filled with 10 µL PGE. Each group from four group was again subdivided into three subgroups of five animals each and were studied 4, 8, 12 weeks after surgery.
Results- In all subgroups behavioral testing and sciatic nerve functional study confirmed faster and better recovery of regenerated axons in CHIT/PGE than in CHIT group (P < 0.05).Gastrocnemius muscle mass in CHIT/PGE was significantly more than in CHIT group. Morphometric indices of regenerated fibers showed number and diameter of the myelinated fibers in CHIT/PGE were significantly higher than in control group. In immuohistochemistry, location of reactions to S-100 in CHIT/PGE was clearly more positive than in CHIT group.
Conclusions and Clinical Relevance- Response to local treatment of prostaglandin E1 demonstrates that it influences and improves functional recovery of peripheral nerve regeneration.



Recent studies and clinical reports indicate that insertion of a conduit could be an interesting alternative to direct end-to-end suturing of nerve stumps or interposition of an autograft.1,2 Widely accepted method by most surgeons is bridging the defect with an autologous donor nerve. Different graft equivalents have also been applied to bridge the nerve stump and regulated through the interaction of a variety of protein and cell signals.3 Biodegradable nerve guides as a temporary scaffold are better than non-degradable biomaterials because the latter remain in situ as a foreign body and ultimately result in limiting recovery of nerve function.4

Nevertheless, the resistance to biodegradation can be a cause of chronic nerve compression in the long run and a second surgery may therefore be required for its removal. Beneficial effects of chitosan as a conduit in promoting nerve regeneration have already been documented and it seems chitosan as a natural polymer has excellent properties including biocompatibility, biodegradability, non-toxicity and adsorption properties, and might be a suitable functional material for peripheral nerve regeneration.5-7

Following nerve transection Wallerian degeneration occurs which is a sequential pattern of axonal degeneration, myelin degradation and supporting glial cell proliferation. During this process, various events take place, including blood-nerve barrier dysfunction, endoneural space reorganization, and most importantly the induction of an intense inflammatory response, constituted by inflammatory mediator release and production.8,9

Axonal degeneration recruits this response activating Schwann cells and macrophages that proliferate and activate, clearing myelin debris and producing cytokines that perpetuate an inflammatory state. Axonal regeneration is then regulated by the interactions between all the involved cell types and by cytokines, chemokines, growth factors, and other inflammatory mediators.9 All these events culminate in the promotion of an environment suitable for subsequent regeneration, repair, and axon regrowth. Arachidonic acid and its metabolites are known to modulate neuronal function and survival. There is also evidence that arachidonic acid derivatives, such as prostaglandins, are centrally involved in Wallerian degeneration and in axonal regeneration.9

Regarding the association that exists between arachidonic acid derivatives and nerve degeneration and regeneration, the therapeutic modulation of this pathway emerges as a novel strategy aimed at increased motor, sensory, and structural recovery after nerve injury.10 Aimed to study local effects of prostaglandin E1(PGE 1) on peripheral nerve regeneration, the present study was designed to attempt to determine if local PGE 1 do in fact reduce dysfunction after small gap nerve transection injury in the rat sciatic nerve transection model. Assessment of nerve regeneration was based on behavioral, functional (walking track analysis), histomorphometrical and immunohistochemical (Schwann cell detection by S100 expression) assessment at 4, 8, and 12 weeks after surgery.

Materials and Methods

Animals and study design

Forty-five male white Wistar rats weighing approximately 290 g and 3 months age were divided into four experimental groups (n=15), randomly: Sham-operation (SHAM), control (CHIT) and prostaglandin treated (CHIT/PGE) group. Each group was further subdivided into three subgroups of five animals each. A random number generator was used to create a list of random numbers. Two weeks before and during the entire experiments, the animals were housed in individual plastic cages (50 × 40 × 20 cm) with an ambient temperature of 23 ± 3º C, stable air humidity, and a natural day/night cycle. The animals were handled on a regular daily basis for 2 weeks prior to the study in order to acclimatize them with testing area and experiments. This could minimize anxiety related testing inaccuracies. The rats had free access to standard rodent laboratory food and tap water.

Preparation of chitosan conduit

Chitosan solution was prepared by dissolving medium molecular weight, crab shell chitosan (~400kDa, 85% deacetylated) (Fluka, Sigma-Aldrich St. Louis, MO, USA) in an aqueous solution (1% v/v) of glacial acetic acid (Merck, Darmstadt, Germany) to a concentration of 2% (w/v) while stirring on a magnetic stirrer-hot plate. The solution was stirred with low heat (at 50oC) for 3hour. The resultant chitosan solution was filtered through a Whatman No. 3 filter paper then vacuum filtration to remove any un-dissolved particles. To overcome the fragility of chitosan, glycerol (Sigma Chemical Co., St. Louis, MO, USA) was added as 30% (w/w) of the total solid weight in solution.23 Chitozan conduit was made according to the method described by others11 by gentle injection of the prepared solution into a home- made mold.The prepared conduit was 2 mm in external diameter, 1.8 mm in internal diameter and 10 mm in length. This internal diameter complies with optimal function in rat models.12

Grafting procedure

Animals were anesthetized by intraperitoneal administration of ketamine 5%, 90mg/kg (Ketaset 5%; Alfasan, Woerden, The Netherlands) and xylazine hydrochloride 2%, 5mg/kg (Rompun 2%, Bayer, Leverkusen, Germany). The procedures were carried out based on the guidelines of the Ethics Committee of the International Association for the Study of pain.13 The University Research Council approved all experiments.

Through a muscle splitting approach, the plane between gluteus maximus and biceps femoris was developed 13 and the right sciatic nerve was clearly visible on the underlying hamstrings muscles. Sutures were passed through the nerve epineurium (one on each side), 3 mm apart at a level of 1 cm above the trifurcation of the nerve. Sutures had the same circumferential orientation on the nerve to restore spatial longitudinal nerve continuity. Before transection, both needles were driven through chitosan conduit at each side 2 mm from the edge of the conduit. This facilitated proper and prompt insertion before endoneurial edema obscured the cut ends. Afterward, a complete transection between the sutures was undertaken and the cut ends of the nerve were driven carefully with the aid of the sutures inside the chitosan conduit and held in place.

A second epineurial suture was placed, at each side and through the conduit. After placement, the chambers were filled with10 µL PGE as CHIT/PGE group or with the same volume phosphate buffered solution as a control. In the sham-operation group (SHAM), the left sciatic nerve was exposed through a gluteal muscle incision and after careful homeostasis the muscle was sutured with Vicryl (Ethicon, Norderstedt) 4/0 sutures, and the skin with 3/0 nylon (Dafilon, B/Braun, Germany). The rats were observed on a heating pad during recovery.

The animals of each group were anesthetized by intraperitoneal administration of ketamine -xylazine (see above) and were perfused via left cardiac ventricle with a fixative containing 2% paraformaldehyde and 1% glutaraldehyde buffer (pH 7.4) at 4, 8 and 12 weeks after surgery.

Behavioral Testing

Functional recovery of the nerve was assessed using the Basso, Beattie, and Bresnahan (BBB) locomotor rating scale for rat hind limb motor function.14 The method has been described by others in a previous study.14

Functional assessment of reinnervation

Sciatic functional index (SFI)

Walking track analysis was performed 4, 8 and 12 weeks after surgery based on the method described by others.15,16

Static sciatic index (SSI)

The SSI is a time-saving and easy technique for accurate functional assessment of peripheral nerve regeneration in rats and is calculated using the static factors, not considering the print length factor (PL), that was described by the authors in previous studies.15,17 When no footprints were measurable, the index score of −100 was given.18

Muscle mass measurement 

Recovery assessment was also indexed using the weight ratio of the gastrocnemius muscles at 12 weeks after surgery based on a previous study. 15All measurements were made by two independent observers unaware of the analyzed group.

Histological preparation and quantitative morphometric studies

Midpoint of SHAM, CHIT and CHIT/PGE groups were harvested and fixed in 2.5 percent glutaraldehyde. The nerves were post fixed in OsO4 (2%, 2 h), dehydrated through an ethanol series and embedded in Epon. Semi thin transverse (5 µm) sections were next stained with toluidine blue and examined under light microscopy. Based  on the prevouis studies  an  image  analyzing software was used for histomorphometrical analysis. 15,19

Statistical Analysis

Experimental results were expressed as means ± SD. Statistical analyses were performed using PASW 18.0 (SPSS Inc., Chicago, IL, USA). Model assumptions were evaluated by examining the residual plot. Results were analyzed using a factorial ANOVA with two between-subjects factors. Dunnett's test for pair-wise comparisons was used to examine the effect of time and treatments. The data were presented as mean ± SD and differences were considered significant when P < 0.05.

Immunohistochemical analysis

For immunohistochemical studies, anti- S- 100 (1:200, DAKO, USA) was used. Anti S-100 is a marker for myelin sheath. The procedures were based on a method described in a previous study.15



BBB recovery

The recovery of hindlimb based on BBB scores are shown in Figure 1. The statistical findings showed that administration of PGE improved locomotion of injured limb compared to the control group (P<0.05).

Recovery of sciatic nerve function and reinnervation SFI outcome

The findings of SFI assessmnets are shown in in Figure 2. Transection of the nerved resulted in complete dysfunction immediately after operation. At the end of the study period, animals of PGE treated group achieved a mean value for SFI of -19.8 ± -3.21whereas in control group a mean value of -23 ± -3.6 was found. The statistical analyses revealed that the recovery of nerve function was significantly (P<0.05) different between CHIT and CHIT/PGE groups and application of PGE in chitosan conduit significantly improved functional recovery in the course of time.

SSI outcome 

The findins of SSI assessments are depicted in Figure 3. Changes in SSI were significant at weeks 4, 8 and 12 weeks of recovery (P < 0.05). The contrasts indicated SSI values at week 12 to differ significantly from those obtained from control, a trend also noticed for SFI (P<0.05).

Muscle mass measurement

The findings of muscle mass assessments demonstrated that the weight of muscle in CHIT/PGE group was significantly higher than CHIT group (P<0.05).

Histological and morphometric findings

Table 1 shows quantitative morphometric analyses of regenerated nerves for each of the experimental groups. Statistical analysis by means of a one-way ANOVA test showed that 4 weeks after surgery, CHIT/PGE group presented significantly greater nerve fiber, axon diameter and myelin sheath thickness compared to CHIT animals (P<0.05). Using Factorial ANOVA analysis with two between-subjects factors (Group × time); in CHIT/PGE group axon diameters did not show significant difference between 8 and 12 weeks (P>0.05). Increase in mean thickness of myelin sheath did not show statistical difference between 8 and 12 weeks inside CHIT/PGE and CHIT groups (Fig 5-7) (P> 0.05).


The finding of immunohistochemical assessments showed more positive reaction of myelin sheath in CHIT/PGE group compared to CHIT group. Figure 8 showes immunohistochemical analysis of the regenerated nerves in experimental gtoup.


In the present study we used chitosan as a scaffold for keeping the delivered drug in situ. Selection of an appropriate method to evaluate functional recovery of nerve regeneration is extremely influential. Castaneda et al,20 suggested that arrival of sprouts from the proximal stump at the distal nerve stump does not necessarily imply recovery of nerve function. Information taken from BBB scale may be invaluable in evaluation of peripheral nerve process. Results of the present study showed that PGE treated animals had been improved in locomotion of the operated limb compared to the control group during the study period. Walking track analysis and static sciatic index has frequently been used to reliably determine functional recovery following nerve repair in rat models.16,17,21 The present study again showed similar results taken from both SFI and SSI assessments.

Walking is a coordinated activity involving sensory input, motor response and cortical integration.4 Therefore, walking track analysis, sciatic function index, is a comprehensive test. The results of the present study showed that PGE 1 when loaded in a chitosan conduit ended up a faster functional recovery of the sciatic nerve.

As the posterior tibial branch of the sciatic nerve regenerates into the gastrocnemius muscle, it will regain its mass proportional to the amount of axonal reinnervation.22 In the present study 12 weeks after surgery the muscle mass was found in both experimental groups. However, CHIT/PGE group showed significantly greater ratios of the mean gastrocnemius muscle weight than CHIT group indicating indirect evidence of successful end organ reinnervation.

Although both morphological and functional data have been used to assess neural regeneration after induced crush injuries, the correlation between these two types of assessment is usually poor. 23 Classical and newly developed methods of assessing nerve recovery, including histomorphometry, retrograde transport of horseradish peroxidase and retrograde fluorescent labeling24,25 do not necessarily predict the reestablishment of motor and sensory functions.20,26, 27 Although such techniques are useful in studying the nerve regeneration process, they generally fail in assessing functional recovery.23 Therefore, research on peripheral nerve injury needs to combine both functional and morphological assessment.

In the histological studies, quantitative morphometrical indices of regenerated nerve fibers showed significant difference between CHIT/PGE and CHIT groups indicating beneficial effect of local PGE 1 on the nerve regeneration. However, there was no significant difference in functional and morphometric indices in animals of CHIT/PGE group within study period. Regarding better functional and morphometric indices in group CHIT/PGE versus group CHIT at the end of the study period, it could be stated that local administration of prostaglandin E1 both accelerated and improved the process of nerve regeneration.

In immunohistochemistry the expression of axon and myelin sheath special proteins was evident in both groups which indicated the normal histological structure. The location of reactions to S-100 in CHIT/PGE group was clearly more positive than CHIT group further implying that both regenerated axon and Schwann cell-like cells existed and were accompanied by the process of myelination and the structural recovery of regenerated nerve fibers.

After nerve injury, increased cyclooxygenase expression induces the production of PG in nerve terminals and nonneural cells in the surrounding areas. This process is known to initiate hyperalgesia and neuropathic pain.28,29 Prostaglandins are produced in important quantities, and for prolonged time periods, both directly by injured nerves and macrophages in response to soluble factors produced by injured nerves.30 It has been shown that prostanoid receptors, effectors of biological actions of prostaglandins, are expressed in Schwann cells and could modulate Schwann cell function in vivo.31 Morover, it has been shown that prostaglandin E2 could modulate microglial migration and function.32 Prostaglandins have also been shown that interact with nerve growth factor in the regulation of inflammatory responses and degeneration following injury.33 After nerve injury prostaglandins play a crucial role in nerve degeneration and regeneration. These are vasoactive molecules and their action in blood-flow homeostasis and inflammation during nerve injury could be important. Prostaglandin E1 diminishes peripheral nerve ischemia-reperfusion injury, probably through such a mechanism.34 Following nerve crush injury, PG E1treatment has resulted in reduced injury, increased repair rates and the upregulation of vascular endothelial growth factor.35 Schratzberger et al.,36 showed that vascular endothelial growth factor gene transfer significantly increased nerve blood flow as well as the amount of vasculature in nerves, suggesting that the induction of local angiogenesis ameliorates experimental neuropathy. One mechanism that PGE1 can promote the repair of peripheral nerve with crushing lesion, could be via increasing the expression of vascular endothelial growth factor.35 It has been reported by clinical and experimental studies that vasoactive treatment can alleviate the effects of lesions in peripheral nerves.37,38

The induction of neuronal apoptosis is a recognized phenomenon after nerve injury that contributes to the physiopathology of nerve degeneration. The administration of PGE1 inhibits neuronal apoptosis in the spinal cord after sciatic nerve constriction injury, independently of changes in local blood flow.39 This suggests that neuroprotective mechanism of PG E1 is not solely dependent on its vasoactive properties. Apartfrom hyperalgesia and blood-flow regulation, prostaglandins also reported to contribute to the molecular and cellular process of nerve degeneration and regeneration.10

Further studies on sciatic nerve crush injury also showed that PGE1 both reduced apoptosis and improved neuronal regeneration.40 Prostaglandins are known to modulate the upregulation of heat-shock protein-70 expression, a protein response known to participate in the maintenance of neuron survival after nerve injury.41,42 After nerve injury, macrophages migrate into the area and initiate degenerative and regenerative processes.

Even though our study shows the neuroprotective action of local PGE in peripheral nerve injuries, data regarding the molecular mechanisms leading to the neuroprotective action remain to be investigated in depth. We have not given the histological and molecular evidence for neuroprotective action of PGE. This may be considered as a limitation to our study.

Therefore, the authors stress that the aim of the current investigation was to evaluate a single local dose and clinical treatment potential of prostaglandin E1 on nerve regeneration. The results of the present study indicated that a single local administration of PGE at the site of transected nerve could be of benefit after chitosan graft tubulization.


In conclusion, in the present study prostaglandin E1 applied locally at the time of sciatic nerve repair using chitosan conduit neurorrhaphy demonstrated promising results in nerve regeneration. Thus, dose–response studies should be conducted prostaglandin E1 to determine the combination of graft and the compound that achieve maximal efficacy in nerve transection models.


The authors like to thank Dr. Rahim Mohammadi, Mr. Mohammad–Hasan Matin, Mr.Valinezhad and Mr. Ansarinia, Department of Clinical Sciences of the Faculty of Veterinary Medicine of the Urmia University and Mr. Jaafary, Urmia Pathobiology Center, for their expert technical help.

1. Pfister LA, Papaloizos M, Merkle HP, Gander B. Nerve conduits and growth factor delivery in peripheral nerve repair. Journal of Peripheral Nervous System. 2007; 12: 65-82.
2. Schmidt CE, Leach JB. Neural tissue engineering: strategies for repair and regeneration. Annual Review of Biomedical Engineering 2003;5:293-347.
3. Evans GR. Peripheral nerve injury: A review and approach to tissue engineered constructs. Anatamical Record 2001;263:396-404.
4. Rosales-Cortés M, Peregrina-Sandoval J, Bañuelos-Pineda J, Sarabia-Estrada R, Gómez-Rodiles CC, Albarrán-Rodríguez E, Zaitseva GP, Pita-López M. Immunological study of a chitosan prosthesis in the sciatic nerve regeneration of the axotomized dog. Journal of Biomaterials Applications 2003;18:15-23.
5. Wang A1, Ao Q, Wei Y, Gong K, Liu X, Zhao N, Gong Y, Zhang X. Physical properties and biocompatibility of a porous chitosan-based fiberreinforced conduit for nerve regeneration. Biotechnology Letters 2007;29:1697-1702.
6. Lin Y-L, Jen J-C, Hsu S-H, Chiu IM. Sciatic nerve repair by microgrooved nerve conduits made of chitosan-gold nanocomposites. Surgical Neurolology 2008;70:9-18.
7. Wang G, Lu G, Ao Q, Gong Y, Zhang X. Preparation of cross-linked carboxymethyl chitosan for repairing sciatic nerve injury in rats. Biotechnology Letters 2010; 32:59-66.
8. Dubov´y, P. Wallerian degeneration and peripheral nerve conditions for both axonal regeneration and neuropathic pain induction. Annals of Anatomy 2011;4:267–275.
9. Cámara-Lemarroy CR, Guzmán-de la Garza FJ, Fernández-Garza NE. Molecular inflammatory mediators in peripheral nerve degeneration and regeneration. Neuroimmunomodulation 2010;17:314–4.
10. Cámara-Lemarroy CR, Gonzalez-Moreno EI, Guzman-de la Garza FJ, Fernandez-Garza NE. Arachidonic acid derivatives and their role in peripheral nerve degeneration and regeneration. The Scientific World Journal doi:10.1100/2012/168953.
11. Ao Q, Wang AJ, Cao WL, Kong L, He Q, Gong Y, Zhang X. Manufacture of multimicrotubule chitosan nerve conduits with novel molds and characterization in vitro. Journal of Biomedical Materials Res Part A 2006;77:11-18
12. den Dunnen WF, Stokroos I, Blaauw EH, Holwerda A, Pennings AJ, Robinson PH, Schakenraad JM. Light-microscopic and electron microscopic evaluation of short- term nerve regeneration using a biodegradable poly (DL-lactide-epsilon-caprolacton) nerve guide. Journal of Biomedical Materrials Research 1996;31:105-115.
13. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983;16:109-110.
14. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. Journal of Neurotrauma 1995;12:1-21.
15. Mohammadi R1, Esmaeil-Sani Z, Amini Effect of local administration of insulin-like growth factor I combined with inside-out artery graft on peripheral nerve regeneration. Injury 2013;44:1295-301.
16. Bain JR, Mackinnon SE, Hunter DA. Functional evaluation of complete sciatic, peroneal, and posterior tibial nerve lesions in the rat. Plastic Reconstructive Surgery 1989;83:129-36.
17. Bervar M. Video analysis of standing—an alternative footprint analysis to assess functional loss following injury to the rat sciatic nerve. Journal of Neuroscience
Methods 2000;102:109-116.
18. Dijkstra JR, MeekMF, Robinson PH, Gramsbergen A. Methods to evaluate functional nerve recovery in adult rats: walking track analysis and the withdrawal reflex. Journal of Neuroscience Methods 2000;96:89-96.
19. Geuna A, Gigo-Benato D, Rodrigues AC. On sampling and sampling errors in histomorphometry of peripheral nerve fibers. Microsurgery 2003;23:72-76.
20. Castaneda F, Kinne RK. Omental graft improves functional recovery of transected peripheral nerve. Muscle Nerve 2002;26:527532.
21. de Medinaceli L, Freed WJ, Wyatt RJ. An index of the functional condition of rat sciatic nerve based on measurements made from walking tracks. Experimental Neurology 1982;77:634-643.
22. Dellon AL, Mackinnon SE. Sciatic nerve regeneration in the rat.Validity ofwalking track assessment in the presence of chronic contractures. Microsurgery 1989;10:220-225.
23. Shen N, Zhu J. Application of sciatic functional index in nerve functional assessment. Microsurg 1995;16:552-555.
24. Mackinnon SE, Hudson AR, Hunter DA. Histologic assessment of the nerve regeneration in the rat. Plastic Reconstructive Surgery 1985;75:384-388.
25. Mackinnon SE, O’Brien JP, Dellon AL, McLean AR, Hudson AR, Hunter DA. An assessment of the effects of internal neurolysis on a chronically compressed rat sciatic nerve. Plastis Reconstructive Surgery 1988;81:251-258.
26. Almquist E, Eeg-Olofsson O. Sensory-nerveconduction velocity and two-point discrimination in sutured nerves. Journal of Bone Joint Surgery (Am) 1970;52:791-796
27. Varejão AS, Melo-Pinto P, Meek MF, Filipe VM, Bulas-Cruz J. Methods for the experimental functional assessment of rat sciatic nerve regeneration. Neurological Research 2004;26:186-194.
28. Ma W, Eisenach JC. Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain. European Journal of Neuroscience 2002;15:1037–47.
29. Syriatowicz JP1, Hu D, Walker JS, Tracey DJ. Hyperalgesia due to nerve injury: role of prostaglandins. Neuroscience 1999;94:587–94.
30. Muja N, DeVries GH. Prostaglandin E2 and 6- ketoprostaglandin F1α production is elevated following traumatic injury to sciatic nerve. Glia 2004;46:116–29.
31. Muja N, Nelson JK, DeVries GH. Schwann cells express IP prostanoid receptors coupled to an elevation in intracellular cyclic AMP. Journal of Neuroscience Research, 2007;85:1159–169.
32. Kunori S, Matsumura S, Okuda-Ashitaka E, Katano T, Audoly LP, Urade Y, Ito S.. A novel role of prostaglandin E2 in neuropathic pain: blockade of microglial migration in the spinal cord. Glia 2011;59:208–18.
33. Marshall JS, Gomi K, Blennerhassett MG, Bienenstock J. Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoiddependent mechanism. Journal of Immunology 1999; 162:4271–76.
34. Milcan A, Arslan E, Bagdatoglu OT, Bagdatoglu C, Polat G, Kanik A, Talas DU, Kuyurtar F.. The effect of alprostadil on ischemia-reperfusion injury of peripheral nerve in rats. Pharmacological Research 2004; 49:67–72.
35. Tang J, Hua Y, Su J, Zhang P, Zhu X, Wu L, Niu Q, Xiao H, Ding X. Expression of VEGF and neural repair after alprostadil treatment in a rat model of sciatic nerve crush injury. Neurology India 2009; 57:387–94.
36. Schratzberger P1, Walter DH, Rittig K, Bahlmann FH, Pola R, Curry C, Silver M, Krainin JG, Weinberg DH, Ropper AH, Isner JM. Reversal of experimental diabetic neuropathy by VEGF gene transfer. Journal of Clinical Investigation 2001;107: 1083–92.
37. Bischoff B1, Romstöck J, Fahlbusch R, Buchfelder M, Strauss C. Intraoperative brainstem auditory evoked potential pattern and perioperative vasoactive treatment for hearing preservation in vestibular schwannoma surgery. Journal of Neurololgy Neurosurg Psychiatry 2008;79:170-75.
38. Uehara K1, Sugimoto K, Wada R, Yoshikawa T, Marukawa K, Yasuda Y, Kimura Y, Yagihashi S. Effects of cilostazol on the peripheral nerve function and structure in STZ-induced diabetic rats. Journal of Diabetes and its Complications 1997;11:194-202.
39. Kawamura T1, Akira T, Watanabe M, Kagitani Y. Prostaglandin E1 prevents apoptotic cell death in superficial dorsal horn of rat spinal cord. Neuropharmacology, 1997 ;36:1023–30.
40. Kogawa S1, Yasuda H, Terada M, Maeda K, Kikkawa R. Apoptosis and impaired axonal regeneration of sensory neurons after nerve crush in diabetic rats. NeuroReport 2000;11:663–67.
41. Sharma HS, Westman J. Prostaglandins modulate constitutive isoform of heat shock protein (72 kD) response following trauma to the rat spinal cord. Acta Neurochirurgica, Supplement 1997;1997:134–37.
42. Newfry G.A, Jones KJ. Differential effects of facial nerve transection on heat shock protein 70 expression in the developing and adult hamster facial nucleus. Metabolic Brain Disease 1998;13:253–57.